ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note
scaffold_1_1161 # 1286432 # 1286971 # -1 # ID=1_1161;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.556	scaffold_1_1161 	1286432	1286971	-	Strict	700	24.2534	ugd	100.0	3003577	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	pmr phosphoethanolamine transferase	ATGTCATCGCCAGGCGTTGTGAAGTCGGGGACAGAGACAGTCGAGCTCACGGAGAAGCAAAGTAGCTCGTCTCCTAGCTCCACCACGGCTTCCATACGGCTGGAAGCCCAGAATGCCGCACTCGCTGCTGACAAGGCGGAGGAAGCACCCCAAGGGCCCGCGGATGAAGTCGCTGGCGAGGATGACAACGTCGAGTACCCCAGGCGGTTCCGACTCGCCGTTATCGTCCTCGGTCTGGCAATGGCCGTCTTCATCGTCTTCTTCGACATGACCGTGATCTCGACCGCCATCCCTTCAATCACAAATCAGTTCAACTCCTTGGATGACATCGGCTGGTATGGCTCGGCGTACATGTTAACTGTAAGGCTCAAATCACCTCCTGAGATCGCGCATTCTCGGCTTAAAAAATGGCATCCTAACACTGTGGAAGCTTTGTTCTTTTCAGCTGATCTACGGCAAAGTGTACGAGCTCTTCTCGCTCAAGTGGACGTTTACGGCGGCTATTGTCTTCCAGTGCCTGGGTTCGGCGGTGTGCGGTAG	MSSPGVVKSGTETVELTEKQSSSSPSSTTASIRLEAQNAALAADKAEEAPQGPADEVAGEDDNVEYPRRFRLAVIVLGLAMAVFIVFFDMTVISTAIPSITNQFNSLDDIGWYGSAYMLTVRLKSPPEIAHSRLKKWHPNTVEALFFSADLRQSVRALLAQVDVYGGYCLPVPGFGGVR	MKITISGTGYVGLSNGLLIAQNHEVVALDILPSRVAMLNDRISPIVDKEIQQFLQSDKIHFNATLDKNEAYRDADYVIIATPTDYDPKTNYFNTSSVESVIKDVVEINPYAVMVIKSTVPVGFTAAMHKKYRTENIIFSPEFLREGKALYDNLHPSRIVIGERSERAERFAALLQEGAIKQNIPMLFTDSTEAEAIKLFANTYLAMRVAYFNELDSYAESLGLNSRQIIEGVCLDPRIGNHYNNPSFGYGGYCLPKDTKQLLANYQSVPNNLISAIVDANRTRKDFIADAILSRKPQVVGIYRLIMKSGSDNFRASSIQGIMKRIKAKGVEVIIYEPVMKEDSFFNSRLERDLATFKQQADVIISNRMAEELKDVADKVYTRDLFGSD	46.13	gnl|BL_ORD_ID|916|hsp_num:0	842	True	loose hit with at least 95 percent identity pushed strict
scaffold_1_2547 # 2879909 # 2880163 # -1 # ID=1_2547;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=11-12bp;gc_cont=0.471	scaffold_1_2547 	2879909	2880163	-	Strict	450	21.9422	ANT(9)-Ia	100.0	3002630	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	ANT(9)	ATGGGAGAATCCGACGATCTCTTCATAAAGAATGGACTGCAGTACCCCCCAAAAAGGGAGAGACCCGAAGCAGTGGGTGTTCAATTGATTGGGTGGTTGTGTTGTGACTGTAGAGAAAAGCTGGTGGTGTGGACGGGTGGAGGCTATACAGTGGATCCTTGTGACGTAACAGGTCTGCAAAACCGGACCTTGGCTTTCTTACTAAGATGCAGTCATTGTGATATAATAGGAGATCAGATCTGCTTCGCGTCTTAA	MGESDDLFIKNGLQYPPKRERPEAVGVQLIGWLCCDCREKLVVWTGGGYTVDPCDVTGLQNRTLAFLLRCSHCDIIGDQICFAS	MSNLINGKIPNQAIQTLKIVKDLFGSSIVGVYLFGSAVNGGLRINSDVDVLVVVNHSLPQLTRKKLTERLMTISGKIGNTDSVRPLEVTVINRSEVVPWQYPPKREFIYGEWLRGEFENGQIQEPSYDPDLAIVLAQARKNSISLFGPDSSSILVSVPLTDIRRAIKDSLPELIEGIKGDERNVILTLARMWQTVTTGEITSKDVAAEWAIPLLPKEHVTLLDIARKGYRGECDDKWEGLYSKVKALVKYMKNSIETSLN	32.31	gnl|BL_ORD_ID|1302|hsp_num:0	1386	True	loose hit with at least 95 percent identity pushed strict
scaffold_2_168 # 223852 # 223983 # -1 # ID=2_168;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.455	scaffold_2_168 	223852	223983	-	Strict	800	20.0162	PDC-376	100.0	3005302	protein homolog model	n/a	n/a	monobactam; carbapenem; cephalosporin	antibiotic inactivation	PDC beta-lactamase	ATGGCGTACAGTGGCAACCTTGCCAGTCTGCATTGGCCCTACCAAATATTACGTTCTGAGTTCTTCCAGATACTGTACTCTGTCGCTTGCTTCGGCGCAAAGGATGCTGAATTTTGCAAAGTTGATACATGA	MAYSGNLASLHWPYQILRSEFFQILYSVACFGAKDAEFCKVDT	MRDTGFPCLCGIAASTLLFAATSAIAGEAPADRLKTLVDAAVQPVMKANDIPGLAVAISLKGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASLHWPALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYTPGSQRLYSNPSIGLFGYLAARSLGQPFERIMEQQLFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVGPGPLDAEGYGVKTSAADLLRFVDANLHPERLVKPWAQALDATHRGYYKVGDMTQGLGWEAYDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFIPGSDLGLVILANRNYPNAERVKIAYAILSGLEQQAKVPLKR	10.83	gnl|BL_ORD_ID|3073|hsp_num:0	4034	True	loose hit with at least 95 percent identity pushed strict
scaffold_2_1443 # 1862215 # 1862361 # 1 # ID=2_1443;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.585	scaffold_2_1443 	1862215	1862361	+	Strict	200	20.0162	FosA4	100.0	3003210	protein homolog model	n/a	n/a	fosfomycin	antibiotic inactivation	fosfomycin thiol transferase	ATGCTCTTGTTGGCGGGAACGGGCTTGCCGCAGCTCGACAAGGAACTGAGGGTACTTTATTCCGTCGTCTTTATCGCCAGGTGGGATTCCGGGGCGGTCGGGGGCCGCCGGATATTCCCAGTCGAAGTCAACGCGATCGAGGTTTAA	MLLLAGTGLPQLDKELRVLYSVVFIARWDSGAVGGRRIFPVEVNAIEV	MLQGLNHLTLAVSDLASSLAFYQRLPGMRLHARWDSGAYLSCGALWLCLSLDAQRRKTPAQESDYTHYAFSVAEEHFAEVVAQLAHAGAEVWKDNRSEGASYYFLDPDGHKLELHVGHLAQRLAACRERPYKGMVFFD	34.78	gnl|BL_ORD_ID|1869|hsp_num:0	1979	True	loose hit with at least 95 percent identity pushed strict
scaffold_2_2856 # 3586962 # 3587129 # 1 # ID=2_2856;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.423	scaffold_2_2856 	3586962	3587129	+	Strict	400	21.1718	Erm(38)	100.0	3000601	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGCAGCTTTATTACATGTTTATTCACTTACTCAGTATTTACCCCCTCTTAGCGACTACCCCTGAAATATCATGGCCATGGTTCGAAGCCATAGTCTTGATTCAAAACCAGCTGTTCGCGATTCGTCCAAGTCACTTTAATTTGCAAAAGCTGGGCTGTACTGCTTGA	MQLYYMFIHLLSIYPLLATTPEISWPWFEAIVLIQNQLFAIRPSHFNLQKLGCTA	MSTPHHGRHELGQNFLSDRRVIADIVEIVSRTNGPIIEIGAGDGALTIPLQRLARPLTAVEVDARRARRLAQRTARSAPGPASRPTEVVAADFLRYPLPRSPHVVVGNLPFHLTTAILRRLLHGPGWTTAVLLMQWEVARRRAAVGGATMMTAQWWPWFEFGLARKVSAASFTPRPAVDAGLLTITRRSRPLVDVADRARYQALVHRVFTGRGHGMAQILQRLPTPVPRTWLRANGIAPNSLPRQLSAAQWAALFEQTRLTGAQRVDRPRDVQHGRAHRRRGGEVDRPATHHKQTGPVVGQRQPQRGRDADADPDDQRTAPPVTRHHQGERRDEDQADHQDRPLTGEHLAGEFLWRHASFDSSASTTLVSRKARVNGPTPPGLGDT	14.25	gnl|BL_ORD_ID|1030|hsp_num:0	1097	True	loose hit with at least 95 percent identity pushed strict
scaffold_3_1027 # 1152809 # 1153051 # 1 # ID=3_1027;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.556	scaffold_3_1027 	1152809	1153051	+	Strict	650	21.557	MexH	100.0	3000807	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; tetracycline antibiotic; acridine dye; disinfecting agents and intercalating dyes	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGTGTACCGCGTGTCCACCAGGGCAGGAGTGCATCAATGTCTCCGATGTGGACCGTGGAAACAACTCAATGTGTATTGAACCGGTTTTCTGTGGTGGTTTCGCGGGGTACCCTTGCAGGCCAGGTCTGAAATGTATCGACGACCCGAGAGACAAGTGCAGCCCAGACAAGGGTGGGAGGGATTGTGACGGGCTTTGTATCCCCGACATCAATGGGACTAAGTCCGCACTGCCTCCCAGCTGA	MCTACPPGQECINVSDVDRGNNSMCIEPVFCGGFAGYPCRPGLKCIDDPRDKCSPDKGGRDCDGLCIPDINGTKSALPPS	MQKPVLIASAALICAAVIGIAVYATGSAKKDAGGFAGYPPVKVALASVERRVVPRVFDGVGELEAGRQVQVAAEAAGRITRIAFESGQQVQQGQLLVQLNDAVEQAELIRLKAQLRNAEILHARARKLVERNVASQEQLDNAVAARDMALGAVRQTQALIDQKAIRAPFSGQLGIRRVHLGQYLGVAEPVASLVDARTLKSNFSLDESTSPELKLGQPLEVLVDAYPGRSFPARISAIDPLIGKSRTVQVQALLDNPEGLLAAGMFASIRVSRKADAPSLSVPETAVTYTAYGDTVFVAHQDGDRPLSAKRVSVRIGERWDGRVEILQGLAEGDRVVTSGQINLSDGMAVEPVKEDTLSSAAPPVPVAGR	21.62	gnl|BL_ORD_ID|1265|hsp_num:0	1344	True	loose hit with at least 95 percent identity pushed strict
scaffold_3_1546 # 1741938 # 1742144 # 1 # ID=3_1546;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.541	scaffold_3_1546 	1741938	1742144	+	Strict	650	21.557	vanE	100.0	3002907	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; van ligase	ATGGATGACCCTAGTAAACGAAAGCGGCAATGCCCATCCGGAATGGCAGGCATCGGTGACGTGATGGTCAGGAAGCAGCCCCAGAAGGCACCCAAAGAGAATGTCTCGGACGAAAGTTGCGAAGAGATAGTCAGGTCGGAGACGCTGGTGACGCGGTTGGAAACTAGGATCCCCAAGAAATCCAATATTGCCGCGAGGTCGGTATGA	MDDPSKRKRQCPSGMAGIGDVMVRKQPQKAPKENVSDESCEEIVRSETLVTRLETRIPKKSNIAARSV	MKTVAIIFGGVSSEYEVSLKSAVAIIKNMESIDYNVMKIGITEEGHWYLFEGTTDKIKKDRWFLDESCEEIVVDFAKKSFVLKNSKKIIKPDILFPVLHGGYGENGAMQGVFELLDIPYVGCGIGAAAISMNKIMLHQFAEAIGVKSTPSMIIEKGQDLQKVDAFAKIHGFPLYIKPNEAGSSKGISKVERKSDLYKAIDEASKYDSRILIQKEVKGVEIGCGILGNEQLVVGECDQISLVDGFFDYEEKYNLVTAEILLPAKLSIDKKEDIQMKAKKLYRLLGCKGLARIDFFLTDDGEILLNEINTMPGFTEHSRFPMMMNEIGMDYKEIIENLLVLAVENHEKKLSTID	19.32	gnl|BL_ORD_ID|1518|hsp_num:0	1617	True	loose hit with at least 95 percent identity pushed strict
scaffold_3_3583 # 3967256 # 3967399 # 1 # ID=3_3583;partial=00;start_type=GTG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.375	scaffold_3_3583 	3967256	3967399	+	Strict	650	20.7866	MexH	100.0	3000807	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; tetracycline antibiotic; acridine dye; disinfecting agents and intercalating dyes	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGTACACACAAACCACTTTGCCAATCCTGACTGGTAGTATTGTAAAGTTTAATAGTAATAAGTTTGTAAGGGGTAGTGATAATGATTGGGACTATCCGGTAAAGGTTGCGTTAGCTAGTGTTTTGTGTGAAGAGATAGTTTAG	MYTQTTLPILTGSIVKFNSNKFVRGSDNDWDYPVKVALASVLCEEIV	MQKPVLIASAALICAAVIGIAVYATGSAKKDAGGFAGYPPVKVALASVERRVVPRVFDGVGELEAGRQVQVAAEAAGRITRIAFESGQQVQQGQLLVQLNDAVEQAELIRLKAQLRNAEILHARARKLVERNVASQEQLDNAVAARDMALGAVRQTQALIDQKAIRAPFSGQLGIRRVHLGQYLGVAEPVASLVDARTLKSNFSLDESTSPELKLGQPLEVLVDAYPGRSFPARISAIDPLIGKSRTVQVQALLDNPEGLLAAGMFASIRVSRKADAPSLSVPETAVTYTAYGDTVFVAHQDGDRPLSAKRVSVRIGERWDGRVEILQGLAEGDRVVTSGQINLSDGMAVEPVKEDTLSSAAPPVPVAGR	12.70	gnl|BL_ORD_ID|1265|hsp_num:0	1344	True	loose hit with at least 95 percent identity pushed strict
scaffold_5_2093 # 1998003 # 1998146 # 1 # ID=5_2093;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.451	scaffold_5_2093 	1998003	1998146	+	Strict	496	20.4014	IMP-68	100.0	3005019	protein homolog model	n/a	n/a	carbapenem; cephalosporin; cephamycin; penam; penem	antibiotic inactivation	IMP beta-lactamase	ATGAGTCAGTATCGTAGGTCACGCATTGTGAAATTGTTAAGGGAATTAGTAACAGCAGCCATTAATAAGGAAGTGGTACACTGTGCCTGGCCCCACTCTGCCCCATTCTACCAAAATTTCTACATATCTATGCGCGGACGCTGA	MSQYRRSRIVKLLRELVTAAINKEVVHCAWPHSAPFYQNFYISMRGR	MKKLFVLCIFLFCSITAAGASLPDLKIEKLEEGVYVHTSFEEVNGWGVVSKHGLVVLVNTDAYLIDTPFTAKDTEKLVNWFVERGYKIKGSISSHFHSDSTGGIEWLNSQSIPTYASVLTNELLKKDGKVQAKNSFSGVSYWLVKNKIEVFYPGPGHTQDNVVVWLPKNKILFGGCFVKPYGLGNLDDANVEAWPHSAEKLISKYGNAKLVVPGHSDIGDASLLKLTWEQAVKGLNESKKSNTVH	19.18	gnl|BL_ORD_ID|2810|hsp_num:0	3762	True	loose hit with at least 95 percent identity pushed strict
scaffold_5_2602 # 2471917 # 2472132 # -1 # ID=5_2602;partial=00;start_type=GTG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.537	scaffold_5_2602 	2471917	2472132	-	Strict	900	21.1718	lsa(D)	100.0	3005121	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; tetracycline antibiotic; oxazolidinone antibiotic; phenicol antibiotic; pleuromutilin antibiotic	antibiotic target protection	ABC-F ATP-binding cassette ribosomal protection protein	GTGTGCGGACTGCTGGATTGCTTCAGGTCTCGGATGCGAAGTCAGGGTATTCGTAGTTATTGGCAAAGTGCCGTACATGATAGCTGGGGTTGCACATTAGCCGATAACAGAGGTTTCTTGGAAACACACCCGGCCGGCAGACCCAAGACAGGCCAAATGATTCTAGAGAAGAGGAGGAAAAGGAGGGGGGAAAGGGGGGGGAAAGCTGAGGGCTAG	MCGLLDCFRSRMRSQGIRSYWQSAVHDSWGCTLADNRGFLETHPAGRPKTGQMILEKRRKRRGERGGKAEG	MSNIKINNLTFGYTDQLIFDNVNINIDDQWKLGLVGRNGRGKTTLLKILLGEVDVHLEIKTNKSFVYFPQTINDKDQLTLFVLQELADFEQWELERELTLMGVDLDTLWRPFNSLSGGEQTKTLLALLFLDEHNYPLIDEPTNHLDKASREKVAAYLSEKKGYILISHDRNFLNKTTDHTLAIERADLQVYAGNFAIYEEEKRLRDLTEKAQDDKLRKEIGRLKQTAREKEAWSRNLEATKSRKKRGFDSETKRVDKGFIGRKAANMMQKSKNLEKRMKEDIADKELLLKNWEEVPGLEMSVLESHQKRLLTVENLAAGFEDFLFEPVSFTLEQGQVLALTGENGRGKSSLMKVLTGEFTGRYVGTFELAHNLVISEVRQLADNRGFLNEFAKKENLELELFLNNLRKLGVERKVFEQKIENMSQGQQRKVELARALSQPAHIYLWDEPLNYLDVFNQEQIIQMIKRSKPSMLVIEHDQYFVDQVADAQIELIKSSV	14.29	gnl|BL_ORD_ID|2891|hsp_num:0	3847	True	loose hit with at least 95 percent identity pushed strict
scaffold_8_417 # 567334 # 567453 # 1 # ID=8_417;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.575	scaffold_8_417 	567334	567453	+	Strict	500	20.0162	OXA-114a	100.0	3001609	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGGGAGGCAAAGACGTTGCAGGCCCAGGTGCGATTCTTGTGAGGGATTGGCCCGCCCAAAAACTTGCCTCGTTGGCAGATCCCGCCGCTAGTCCCAAACCAGAAAAGGGGCTGCCATAA	MGGKDVAGPGAILVRDWPAQKLASLADPAASPKPEKGLP	MTVRRLSCALGAALSLSALGGGPVQAAVLCTVVADAADGRILFQQGTQQACAERYTPASTFKLAIALMGADAGILQGPHEPVWNYQPAYPDWGGDAWRQPTDPARWIKYSVVWYSQLTAKALGQDRFQRYTSAFGYGNADVSGEPGKHNGTDGAWIISSLRISPLEQLAFLRKLVNRQLPVKAAAYELAENLFEAGQADGWRLYGKTGTGSPGSNGVYTAANAYGWFVGWARKDGRQLVYARLLQDERATRPNAGLRARDELVRDWPAMAGAWRP	14.18	gnl|BL_ORD_ID|1788|hsp_num:0	1892	True	loose hit with at least 95 percent identity pushed strict
scaffold_11_17 # 23241 # 23432 # -1 # ID=11_17;partial=00;start_type=GTG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.531	scaffold_11_17 	23241	23432	-	Strict	700	21.557	vanSC	100.0	3002933	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanS; glycopeptide resistance gene cluster	GTGACAGGCAGAAAACGAGGTTGGGCCAAGCTCCAGAATCCGAAAGGTGGGTATTACCAGAAGACGGAAGAGATGAATCAATTAAGAGAGGGAATTGGGCGCATCAAGCGAACGTCTTTCTTCCTCTCCAGCGAAGGGGAGATGGGGAAACGCGGATGCGGAGTAGAGGTGGAAGAAGGTTTGGCGGTTTAG	MTGRKRGWAKLQNPKGGYYQKTEEMNQLREGIGRIKRTSFFLSSEGEMGKRGCGVEVEEGLAV	MKNRNPLIRKLLTQYFVTTGILLAFLVMIPLVIRFIAGTRTWYGTEPIYYILRFFADRWLFCVAIGALLIWFGTTIYYMTKAIGYLNETIQATTQLIEEPSKRITLSSHLIDVQEEMNQLREKSLQDQRAAKEAEQRKNDLIVYLAHDLRTPLTSVIGYLTLLKEEPQLSNAMRNRYTEIALQKAQRLELLISEFFEITRFNLTTIVLQTETTDLSLMLEQLTFEFLPLLEEKNLNWQLNLQKNVLATVDTEKIARVFDNLIRNAINYSYPDSPLLLELVESDSIHIRLTNRGKTIPEEMIGRLFEPFYRMDSSRATATSGTGLGLPIAKEILLASGGDISAESKDETIIFNVRLPKPANN	17.45	gnl|BL_ORD_ID|906|hsp_num:0	966	True	loose hit with at least 95 percent identity pushed strict
scaffold_11_1326 # 1197675 # 1197818 # 1 # ID=11_1326;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.569	scaffold_11_1326 	1197675	1197818	+	Strict	300	20.4014	AAC(3)-IXa	100.0	3002543	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(3)	ATGGCCAGGGCGCTCGAGCTACTTGTCGACTTCCTTGATTGGCCAGTTGAGGTAAACAATCAGGGATGCTCCTTCCTTGGTCTCCTATGGCAACACGGTGGTGGGGGGGGTTCTGTGCACTTGGCCTGGCTGCAGCTTTCGTGA	MARALELLVDFLDWPVEVNNQGCSFLGLLWQHGGGGGSVHLAWLQLS	MEEMSLLNHSGGPVTRSRIKHDLADLGLKDGDVVIFHTRMSAIGYVAGGTQTIIGALLDVVGARGTLMVPCGWNNAPPYDFLDWPRDWQDALRAEHPAYDPDLSEADYNNGRLPEALPRWPGAIRSRHPDASFAALGPAAAELMAEHPWDHPHGPDTPLARLIAHSGRVLLLGAPLDTMTLLHHAEALADVRSKRFVTYEQPILVNGQRVWRQFRDIDSEEGAFDYSTVRRGVEPFEAIARDMLSAGIGRQGRVGAADSYLFDAGPVFNFAINWIEAKLKR	16.73	gnl|BL_ORD_ID|1915|hsp_num:0	2030	True	loose hit with at least 95 percent identity pushed strict
scaffold_17_544 # 710040 # 710144 # 1 # ID=17_544;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.457	scaffold_17_544 	710040	710144	+	Strict	450	19.631	VMB-1	100.0	3005015	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	VMB beta-lactamase	ATGCGAACCAACGCGGTAGAACCATGGGGCTTGCATCGTATGTGGACCATTTATATCGATAGACAATTACTCCTCCGCTTTGTACATAGTTTTGTGCTGGAGTGA	MRTNAVEPWGLHRMWTIYIDRQLLLRFVHSFVLE	MKYIILFLLLIPSIVFANNEGTKELKLKKLSDNVYQHISYKRVEPWGLIGASGLVVINGTEAHMIDTPWTTQGTKQLIEWIEAKGLTIKSAVVTHFHEDASGDIPLLNDLKIKTYATSLTNKLLKLNQKEVSSDEISSNTFEFIDGVASVFYPGAGHTEDNIVVWLPNEKILFGGCFVKSLKNKNLGYTGDANISEWPNSMQKVINRYPDAKLVVPGHGEVGDVSLLKHTQALALSAAASNKKINKD	13.77	gnl|BL_ORD_ID|2806|hsp_num:0	3758	True	loose hit with at least 95 percent identity pushed strict
scaffold_18_160 # 223095 # 223325 # 1 # ID=18_160;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.571	scaffold_18_160 	223095	223325	+	Strict	750	21.557	smeD	100.0	3003055	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; tetracycline antibiotic; phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGACATGCGCGAGATGGTGGACAAGGTCAAGGCTGGGGAGCCTCTCTACGGAGTGAGCAAGCTTACGCCCTCAATGCAGGGTGTTGCGGCACGGCAGTCTCGGTACTCCGCGCTTTTCACCGGTGTCCTCCCCTGGTTCAACTTTGTCAACCACAACCAGCATGGTGTAGACACTGCAAAGTACTACCAACAGGCTGAGAGGGAACTGGAAGCGGAGCGCAAAGCGTAG	MDMREMVDKVKAGEPLYGVSKLTPSMQGVAARQSRYSALFTGVLPWFNFVNHNQHGVDTAKYYQQAERELEAERKA	MLLSRIRPFALSLAIAATVAACGGQPQAPEQGPGDVTVVTLKSETVGLTRELPGRTNAFLVAEVRPQVNGIVAKRLFTEGGMVKAGEPLYQLDDASYRAQANNARAQLARAEATANAARLSAKRITELAKVDAVSQQDLENAVAAQKQAEADVGAAKASLDAANVTLGYARITAPISGRIGKSSVTQGALVSAGQANALATVQQLDPIYVDLTQSSAELLQLRRELAAGRLQDNQTLPVSILMEDGSTFEHKGTLEFSEVSVDPTTGSFGLRVKVDNPDGLLMPGMYVRAVIGGGVRSDAVLVPMQGIARDPKGDTTAMVVGKDNKVEVRPVKVSRTVGDKWLVEDGLKAGDKVIVEGLQKIGPGMPVKATEKGDAPAKPAAAAQPAAPAGDAK	19.29	gnl|BL_ORD_ID|263|hsp_num:0	284	True	loose hit with at least 95 percent identity pushed strict
scaffold_21_170 # 145034 # 145234 # -1 # ID=21_170;partial=00;start_type=ATG;rbs_motif=AGxAGG/AGGxGG;rbs_spacer=11-12bp;gc_cont=0.537	scaffold_21_170 	145034	145234	-	Strict	555	23.0978	OXA-457	100.0	3003613	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGGAAGCGTGTATAGTAAAACTGAATATACGACCAGTACAATACAAGTTGGCCTTCGATCTTCTCACATACCGAGGACTCTCTCTTACGTGCTTGCATGCCACGCTGTCGGCCCTCCCAACGGATCCGGCACGCTGGTATATATGCGCTGTGTCCCGCCGACCTGTTACCCCGGGGCGCGGCATAGATACCGAGAAGTAA	MEACIVKLNIRPVQYKLAFDLLTYRGLSLTCLHATLSALPTDPARWYICAVSRRPVTPGRGIDTEK	MTVRLFSTALGAALSLSALAGAPAQAAILCTVVADAADGRIVYQQGTQQACAARYTPASTFKLPIALMGADAGILTGPHAPVWNYQPGYPDWGGDAWRQPTDPARWIKYSVVWYSQLTARALGQERFQRYASAFHYGNEDVSGEPGKHNGLDGAWINSSLRISPLEQLAFLRKLVNRQLPVKAAAYDLAENLFEVGEASGWHLYGKTGTGSPGSNGVYTAANAYGWFVGWARKDGRQLVFARLVQDEQATKPNAGLRARDDLMRDWPAMADAPRK	24.00	gnl|BL_ORD_ID|2581|hsp_num:0	3524	True	loose hit with at least 95 percent identity pushed strict
scaffold_21_602 # 554998 # 555321 # 1 # ID=21_602;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.571	scaffold_21_602 	554998	555321	+	Strict	740	22.7126	tet(30)	100.0	3000561	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	GTGTCACTCTTGGCGACTGGAGTCTACGGTATCGTCAAGATGCTATCCACGGTCGTCTTCATGATCTTCATTGTCGATCGCTTCGGCAGACGACCGCCCCTTTTGGTTGGCGCGATTGTCATTATCATCGCGATGTACTACCTCGCCGCCTATGCTAAGATTTCGGGGTCTTTCCACGGGCAGGTTCCCCGCGATAGCGCGTCCAACGCGGCGCTGGCAATGGTCTACATTTTCGTCATAGCCCACAGCGCAAGCTGGACCGGCATTCCGTGCGTCGCTCCCCCTCCTAGCGCTACCTGGCACAGTTGGCTAACACCACCATAG	MSLLATGVYGIVKMLSTVVFMIFIVDRFGRRPPLLVGAIVIIIAMYYLAAYAKISGSFHGQVPRDSASNAALAMVYIFVIAHSASWTGIPCVAPPPSATWHSWLTPP	MNKALIVILSTVALDAIGAGLIFPILPDILVEVTGGGDIGFLYGVMLGVFAVMQFVFSPILGALSDRFGRRPVLLLSLAGTLLDYLVMAFSPLGWVLVVGRAMAGITSANMAVASAYITDITPAEQRAQRFGTVGAVMSLGFIIGPVIGGVIGAWWLRAPFLVAALFNGLNLFVALFVLPESRKAGPGKFAFKELNPLAPLVWLWNFKPLLPLVTVSVVFGLVAAIPGTIWVLYGAERFGWDSVHMGLSLSVFGVSGALAQAFLVGPLSRRFGDLGTLMIGVGFDMLAYMLMAFANQSWMGYAVAPLFALGGVAMPALQSLVTSRVSDDQQGQLQGVLASLMSLAGIIGPVLTTAVFFSTKSIWIGTIWLVGAALYLLALPLFATVKTPKAVAA	27.16	gnl|BL_ORD_ID|1833|hsp_num:0	1917	True	loose hit with at least 95 percent identity pushed strict
scaffold_21_606 # 556740 # 556982 # -1 # ID=21_606;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.551	scaffold_21_606 	556740	556982	-	Strict	740	22.7126	tet(30)	100.0	3000561	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGATGTACTACATCGTCTACATCATGGAGGGTGCCCAGATTGCCTCTCCCCTCCTCACTGCCTCCATCCAGTACATCCTGAACGTCGCCCTGACCCTTCCTGCCATTCTGTACCTGGACAGATTCGGTCGTCGCCCCGCGTTGATCTTTGGATCCTTCGGCATGATGACTTGGCTGTTCATCTCTGGTGAGTCTCTGAAAATGGCGCACCTCACTGCTGACACGACCCCGGGCATGGACTAA	MMYYIVYIMEGAQIASPLLTASIQYILNVALTLPAILYLDRFGRRPALIFGSFGMMTWLFISGESLKMAHLTADTTPGMD	MNKALIVILSTVALDAIGAGLIFPILPDILVEVTGGGDIGFLYGVMLGVFAVMQFVFSPILGALSDRFGRRPVLLLSLAGTLLDYLVMAFSPLGWVLVVGRAMAGITSANMAVASAYITDITPAEQRAQRFGTVGAVMSLGFIIGPVIGGVIGAWWLRAPFLVAALFNGLNLFVALFVLPESRKAGPGKFAFKELNPLAPLVWLWNFKPLLPLVTVSVVFGLVAAIPGTIWVLYGAERFGWDSVHMGLSLSVFGVSGALAQAFLVGPLSRRFGDLGTLMIGVGFDMLAYMLMAFANQSWMGYAVAPLFALGGVAMPALQSLVTSRVSDDQQGQLQGVLASLMSLAGIIGPVLTTAVFFSTKSIWIGTIWLVGAALYLLALPLFATVKTPKAVAA	20.30	gnl|BL_ORD_ID|1833|hsp_num:0	1917	True	loose hit with at least 95 percent identity pushed strict
scaffold_23_501 # 450454 # 450561 # -1 # ID=23_501;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.481	scaffold_23_501 	450454	450561	-	Strict	600	20.4014	BIC-1	100.0	3004753	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	BIC Beta-lactamase	ATGCAGGTTGGTCAAAATTTTCAGATGTATTTCGCCGAGACCTGGCCCGTTGATTACAGCCCAGACATTGTTACCCTTCAATACACTCTCCTCTTGGGGCTGGCATAA	MQVGQNFQMYFAETWPVDYSPDIVTLQYTLLLGLA	MARPSKLALSFSLLLPFLPFTSFAETWPQGDIARQKIVKLEKDFGGRIGVSAIDTGANRTFDFRADERFPLCSSFKGFLAGAVLSHSQQQEGLLEKRIDYKNRVMEPHSPISAQHSSTGMTVAQLAAAALQYSDNGATNLLLENVLGGPAGMTTFMRTLGDTTFRLDRWELELNSAIPGDDRDTSTPHAIARSLQKIALGEALQTAPRQQLVDWLIGNTTGGARIRAGVPVEWVVGDKTGTCGVYGTANDYAVIWPKTSAPIVLAIYTAKPNKEDKHSDAVIAEVTRAVLESFE	11.90	gnl|BL_ORD_ID|2583|hsp_num:0	3561	True	loose hit with at least 95 percent identity pushed strict
scaffold_8_770 # 1052780 # 1053118 # -1 # ID=8_770;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.614	scaffold_8_770 	1052780	1053118	-	Strict	500	22.3274	MexT	100.0	3000814	protein overexpression model	n/a	n/a	fluoroquinolone antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCGCGCTACCGCCGTCGCCGCCATCCTCGCCTCCACGGCTGGCCTTGCCCAGGCCGCCTGCTCGGTCGTCACCGGAGTGCACGTCACCTTCTACGGCGCTCAAGATAACGACCCTGCTGGATCGGATGCCACTGCCTACAACTGTGGTGGGCGCAACAACCATGCCGGTGGCTCCGGTACCTTTGCGAACCCCTTGACGTTTGCCAGTGCTCCGGGCGAGTACAACCAGTGCGAGATCGTCTACTCGCCGTACCTGAAGAGATATCTGCGCATGGAGGACACCTGTGACGCCTGCAGTAAGTGCTTTAGTCCCGAGTTGGACTCGTGGTTTGGCTAG	MRATAVAAILASTAGLAQAACSVVTGVHVTFYGAQDNDPAGSDATAYNCGGRNNHAGGSGTFANPLTFASAPGEYNQCEIVYSPYLKRYLRMEDTCDACSKCFSPELDSWFG	MPVSDPMPLRHLARPRPVSHARLDGEPPRLQPLAPGNEERHEPKRPAPRRSEPADRVRDPDARTQRDPRRRETVPRPAGQPAISAALSRLRTLFDDPLFVRTGRSMEPTARAQEIFAHLSPALDSISTAMSRASEFDPATSTAVFRIGLSDDVEFGLLPPLLRRLRAEAPGFVLVVRRANYLLMPNLLASGEISVGVSYTDELPANAKRKTVRRSKPKILRADSAPGQLTLDDYCARPHALVSFAGDLSGFVDEELEKFGRKRKVVLAVPQFNGLGTLLAGTDIIATVPDYAAQALIAAGGLRAEDPPFETRAFELSMAWRGAQDNDPAERWLRSRISMFIGDPDSL	32.28	gnl|BL_ORD_ID|1524|hsp_num:0	1608	True	loose hit with at least 95 percent identity pushed strict
